Le Lézard
Classified in: Health, Business
Subjects: CCA, ERP

Select Medical Holdings Corporation Announces Estimate of Certain Results for Second Quarter Ended June 30, 2019 in connection with Refinancing Discussions

MECHANICSBURG, Pa., July 18, 2019 /PRNewswire/ -- As previously disclosed, Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) is currently in discussions with its lenders regarding a proposed refinancing of certain of its outstanding indebtedness. In connection with such discussions, Select Medical today announced an estimate of certain results for its second quarter ended June 30, 2019 in advance of the announcement of actual results, which is expected to occur after market close on August 1, 2019.

Select Medical expects its net operating revenue for the second quarter of 2019 to be in the range of $1.360 billion to $1.362 billion. Select Medical expects earnings excluding interest, income taxes, depreciation and amortization, stock compensation expense, non-operating gain (loss), and equity in earnings (losses) of unconsolidated subsidiaries, or Adjusted EBITDA, for the second quarter of 2019 to be in the range of $185.5 million to $187.0 million. The above expectations regarding Select Medical's results for the second quarter of 2019 are management estimates and projections based on currently available information, and are subject to change upon completion of Select Medical's financial statement closing process.

The Company is not providing a reconciliation of estimated Adjusted EBITDA to Net Income for the second quarter of 2019. At this point in its financial statement closing process, the Company is unable to estimate, without unreasonable efforts, certain individual items required to reconcile estimated Adjusted EBITDA with the most directly comparable GAAP financial measure (Net Income). These items include income tax expense and equity in earnings of unconsolidated subsidiaries.

Conference Call

As previously announced, Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 2, 2019, at 9:00am ET. The domestic dial in number for the call is 1-866-440-2669. The international dial in number is 1-409-220-9844. The conference ID for the call is 5489707. The conference call will be webcast simultaneously and can be accessed at Select Medical Holdings Corporation's website www.selectmedicalholdings.com.

For those unable to participate in the conference call, a replay will be available until 12:00pm ET, August 9, 2019. The replay number is 1-855-859-2056 (domestic) or 1-404-537-3406 (international). The conference ID for the replay will be 5489707. The replay can also be accessed at Select Medical Holdings Corporation's website, www.selectmedicalholdings.com.

Company Overview

Select Medical is one of the largest operators of critical illness recovery hospitals (previously referred to as long term acute care hospitals), rehabilitation hospitals (previously referred to as inpatient rehabilitation facilities), outpatient rehabilitation clinics, and occupational health centers in the United States based on the number of facilities. Our reportable segments include the critical illness recovery hospital segment, rehabilitation hospital segment, outpatient rehabilitation segment, and Concentra segment. As of March 31, 2019, Select Medical operated 97 critical illness recovery hospitals in 28 states, 27 rehabilitation hospitals in 11 states, and 1,684 outpatient rehabilitation clinics in 37 states and the District of Columbia. Select Medical's joint venture subsidiary Concentra operated 525 occupational health centers in 41 states. Concentra also provides contract services at employer worksites and Department of Veterans Affairs community-based outpatient clinics. At March 31, 2019, Select Medical had operations in 47 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.

Certain statements contained herein that are not descriptions of historical facts are "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements due to factors including the following:

Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we are under no obligation to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, or otherwise. You should not place undue reliance on our forward-looking statements. Although we believe that the expectations reflected in forward-looking statements are reasonable, we cannot guarantee future results or performance.

Investor inquiries:
Joel T. Veit
Senior Vice President and Treasurer

SOURCE Select Medical Holdings Corporation

These press releases may also interest you

at 00:00
R3 Medical Training is now enrolling for its January 22, 2020 PDO Thread Lift Certification Training Course in Las Vegas, NV. Attendees will perform hands on procedures with thread lifts for the face, body and extremities. Enrollment is limited, so...

at 00:00
R3 Stem Cell is now accepting early bird registration for its upcoming Two Day Regenerative Aesthetics Training Course scheduled for January 23-24th, 2020 in Las Vegas NV at M Resort. The hands on training is exceptional for teaching providers skills...

8 déc 2019
Nurish.Me Inc. (Subsidiary - F/K/A Altavoz Entertainment, Inc.; OTC Pink: AVOZ) (the "Company"), an emerging leader in the dietary supplement industry for delivering clinically proven solutions for brain and immune system support, announces the...

8 déc 2019
Original Notice Why you should take note The Public Health Agency of Canada (PHAC) is collaborating with provincial public health partners, the Canadian Food Inspection Agency (CFIA) and Health Canada to investigate an outbreak of E. coli infections...

8 déc 2019
The organizers of Tremblant's 24h are elated to announce the unprecedented success of their 19th edition. The event culminated in a record fundraising total of $4,789,709 in support of children's causes, nearly $700,000 more than last year. This...

8 déc 2019
The Canadian Food Inspection Agency (CFIA) is warning consumers not to consume the recalled product described below. This product is not likely to be available at retail stores, but may still be in consumer's homes. The following product has been...

News published on 18 july 2019 at 16:30 and distributed by: